Acquired Hemorrhagic Diathesis of Unknown Nature

C. F Borchgrevink; A Hellem; D Voss; B. A Waaler

doi:10.1055/s-0038-1654381

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1959; 03(02): 187-193
DOI: 10.1055/s-0038-1654381

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

Acquired Hemorrhagic Diathesis of Unknown Nature

C. F Borchgrevink

¹Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)

,

A Hellem

¹Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)

,

D Voss

¹Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)

,

B. A Waaler

¹Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)

› Author Affiliations

References
1 Biggs R, Douglas A. S. The thromboplastin generation test. J. clin. Path 1953; 6: 23
2 Borchgrevink C. F, Waaler B. A. The secondary bleeding time. A new method for the differentiation of hemorrhagic disorders. Acta med. scand 1958; 162: 361
3 Hellem A. Demonstration of a factor in blood influencing the adhesivity of platelets to foreign surfaces. Paper no. 313, 7th Congr Int. Soc. Haemat; Rome: 1958
4 Hjort P, Rapaport S. I, Owren P. A. A simple, specific one-stage prothrombin assay using Russell’s viper venom in cephalin suspension. J. Lab. clin. Med 1955; 46: 89
5 Hjort P, Stormorken H. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate. Scand. J. clin. Lab. Invest 1957; 9 29 Suppl 86
6 Nygaard K. K. A direct method of counting platelets in oxalated plasma. Proc. Mayo Clin 1933; 8: 365
7 Nilsson I. M, Blombäck M, Francken I. von: On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand 1957; 159: 35
8 Nilsson I. M, Blombäck M, Jorpes E, Blombäck B, Johansson S. v Willebrand’s disease and its correction with human plasma fraction 1–0. Acta med. scand 1957; 159: 179
9 Owren P. A, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest 1951; 3: 201
10 Stapp W. F. A one-stage method for the assay of antihemophilic factor B (AHF B). With a comment on the antihemophilic factor B (AHF B) concentration in phenyl-indanedione (PID) therapy. Scand. J. clin. Lab. Invest 1958; 10: 169
11 Stefanini M, Dameshek W. The hemorrhagic disorders. Grune & Stratton; New York: 1955: 368
12 Voss D. Untersuchungen zur Gerinnsel-retraction. Paper no. 346, 7th Congr Int. Soc. Haemat; Rome: 1958
13 Waaler B. A. Simultaneous contribution to the formation of thrombin by the intrinsic and extrinsic blood clotting systems. Scand. J. clin. Lab. Invest 1957; 9: 322
14 Waaler B. A. Contact activation of blood. Studies on a plasma factor formed on contact with glass and similar surfaces, and related to the intrinsic blood clotting system Oslo University Press; Oslo: 1959: 133
15 Waaler B. A. Assay of antihemophilic factor A (AHF A)(In press)